Background: Food allergy is a chronic condition with psychosocial consequences for both children and their families. Strict elimination diets and fear of adverse reactions may contribute to maladaptive coping including behaviors avoidant/restrictive food intake disorder (ARFID)‐related eating patterns. Therefore, this study aimed to compare ARFID‐related eating behavior scores between children with food allergy and healthy controls and to identify the affected domains. Methods: In this prospective controlled study, 234 children aged 2–9 years were enrolled, including 117 children with physician‐diagnosed food allergy and 117 age‐ and sex‐matched healthy controls. Eating behaviors were assessed using the Nine Item Avoidant/Restrictive Food Intake Disorder Screen—Parent Report (NIAS‐PR). Total and subscale scores (picky eating, fear, and appetite) were compared between groups. Within the food allergy group, associations between clinical characteristics and NIAS‐PR scores were analyzed. Results: Children with food allergy demonstrated significantly higher NIAS‐PR total scores compared with controls. The median total NIAS score was higher in the patient group than in the control group (17 [11–24] vs. 12 [7–18], p < .001). This difference was primarily driven by higher fear‐ and picky‐eating‐related scores, whereas appetite scores did not differ significantly. Fear subscale scores were significantly higher in children with a history of urticaria or anaphylaxis. Conclusion: Pediatric food allergy is associated with increased ARFID‐related eating behaviors, particularly fear‐ and picky‐eating patterns. In addition, fear‐related scores were higher among children with a history of immediate‐type reactions, such as urticaria and anaphylaxis. These findings suggest that ARFID‐related eating behaviors should be considered in the assessment of children with food allergy.
Phenylketonuria is an inherited metabolic disorder that leads to neurobehavioral dysfunction. The main treatment is a low-phenylalanine diet and/or the cofactor tetrahydrobiopterin. Regular outpatient follow-up care and measurement of the phenylalanine levels in the blood are required. We aimed to analyze the economic burden of phenylketonuria on families and the state. The patients with phenylketonuria were divided into three groups according to their treatment: a low-phenylalanine diet group (n = 50), a tetrahydrobiopterin group (n = 44), and a group taking tetrahydrobiopterin together with the diet (n = 25). A comparative cost analysis was carried out. The annual economic burden to the state was calculated to average EUR 18,801 ± 15,345 and was lowest in the diet group, then in the tetrahydrobiopterin group, and highest in the tetrahydrobiopterin + diet group (p < 0.001). Out-of-pocket costs amounted to EUR 1531 ± 1173 per year, and indirect losses averaged EUR 2125 ± 1930 per year for all families. The economic loss was significantly lower in the families taking tetrahydrobiopterin than in the other groups (p = 0.001). The combined use of medical nutrition and BH4 treatments has been shown to increase the economic burden on the state. Reimbursing low-protein products and increasing the number of patients eligible for financial allowances may reduce the economic burden on families.
12 November 2024 in The Turkish Journal of Pediatrics
Background. Food allergy is a public health issue that has a significant impact on the lives of families. Parental self-efficacy/confidence is important in managing food allergies. The aim of this study is to validate the “Food Allergy Self-Efficacy Scale for Parents” (FASE-P) and assess parental self-efficacy in managing their child’s food allergy. Methods. Turkish version of the FASE-P (T-FASE-P) was administered to 347 parents of children aged 0-18 who had been followed for at least one month due to food allergy at the Pediatric Allergy Clinic of Prof. Dr. Cemil Taşcıoğlu City Hospital between September 1 and December 31, 2023, through face-to-face interviews and online surveys for parents of children with food allergies from the general population. Content validity, exploratory factor analysis (EFA), and confirmatory factor analysis (CFA) were conducted to evaluate the validity of the scale. General Self-Efficacy Scale (GSES) was used for concurrent criterion validity. Internal consistency analysis, test-retest application, and item analysis were conducted to assess its reliability. Results. T-FASE-P scale initially contained 21 items, and the Cronbach’s alpha coefficient (α) calculated in this form was found to be 0.89. Later, when 4 items were excluded, the 17-item version of the scale was calculated as α=0.90. The intra-class correlation coefficient between the test and re-test was found to be 0.972. The content validity index value of the scale was calculated as 0.99, indicating that the content validity was at a sufficient level. In the EFA, it was determined that the scale formed a three-factor structural model and that this model explained 60.82% of the total variance. As a result of the CFA, the fit indices were calculated as χ2/df=2.341, GFI=0.919, TLI=0.950, indicating a good level of fit. Based on the analysis results, T-FASE-P consists of 17 items and three subscales. Conclusion. T-FASE-P scale is a valid and reliable measurement tool that can be used to determine the food allergy self-efficacy of Turkish parents.
Background: Food allergy management requires dietary adherence, prevention of accidental exposures, and prompt reaction management. Identifying sociodemographic factors linked to low self‐efficacy may improve management. Methods: This study was conducted among parents of children diagnosed with food allergy who presented to our clinic. Participants completed the Turkish version of the Food Allergy Self‐Efficacy Scale for Parents (T‐FASE‐P, previously validated as EBA‐ÖZ) and the General Self‐Efficacy Scale (GSES). Results: A total of 280 parents (mothers, 85.4%; fathers, 14.6%) were included in the study. Of the children, 64.6% were boys and 35.4% were girls. The median parental age was 33 years (20–59), and the median child age was 25.5 months (3–213). Parents of children with egg and cow's milk allergy had lower T‐FASE‐P scores, while carrying an epinephrine auto‐injector and baked egg tolerance were associated with higher scores ( p < .05). Lowest scores related to school safety, cross‐contamination, and travel. In multivariable analyses, only school attendance ( p = .004) and cow's milk allergy ( p = .002) remained significant. Subscale analyses showed that school attendance was associated with prevention and recognition/management ( p = .002), parental employment with social activities ( p < .001), and IgE‐mediated allergy with recognition/management ( p = .027), whereas cow's milk allergy was consistently associated with lower scores across all subscales ( p < .05). Conclusion: This study evaluated parental self‐efficacy in relation to demographics. Cow's milk allergy was associated with lower, and carrying an adrenaline auto‐injector with higher self‐efficacy. These findings emphasize the need for targeted support for families managing high‐risk allergens.